6,266 Shares in McKesson Corporation $MCK Acquired by Lingohr Asset Management GmbH

Lingohr Asset Management GmbH bought a new stake in shares of McKesson Corporation (NYSE:MCK) in the third quarter, HoldingsChannel reports. The institutional investor bought 6,266 shares of the company’s stock, valued at approximately $4,841,000.

Several other institutional investors have also added to or reduced their stakes in the business. Brighton Jones LLC grew its position in shares of McKesson by 46.3% during the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock valued at $1,438,000 after acquiring an additional 798 shares during the period. Caxton Associates LLP bought a new stake in McKesson during the first quarter valued at about $233,000. Sivia Capital Partners LLC increased its position in McKesson by 77.9% in the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock worth $502,000 after buying an additional 300 shares in the last quarter. SOA Wealth Advisors LLC. bought a new position in shares of McKesson in the second quarter worth about $121,000. Finally, Pure Financial Advisors LLC lifted its position in shares of McKesson by 9.7% during the 2nd quarter. Pure Financial Advisors LLC now owns 1,108 shares of the company’s stock valued at $812,000 after buying an additional 98 shares in the last quarter. 85.07% of the stock is currently owned by institutional investors.

Insider Activity at McKesson

In other McKesson news, EVP Thomas L. Rodgers sold 276 shares of McKesson stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $816.18, for a total value of $225,265.68. Following the sale, the executive vice president owned 2,268 shares of the company’s stock, valued at $1,851,096.24. The trade was a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the company’s stock in a transaction that occurred on Friday, November 7th. The stock was sold at an average price of $861.63, for a total value of $283,476.27. Following the sale, the chief accounting officer directly owned 328 shares in the company, valued at $282,614.64. This trade represents a 50.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.08% of the company’s stock.

McKesson Stock Performance

MCK opened at $831.32 on Friday. The stock has a market capitalization of $102.61 billion, a price-to-earnings ratio of 25.87, a PEG ratio of 1.35 and a beta of 0.41. The company has a fifty day moving average of $828.09 and a 200 day moving average of $773.56. McKesson Corporation has a fifty-two week low of $570.51 and a fifty-two week high of $895.58.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $9.86 EPS for the quarter, topping the consensus estimate of $8.84 by $1.02. The business had revenue of $103.15 billion for the quarter, compared to analysts’ expectations of $103.80 billion. McKesson had a net margin of 1.04% and a negative return on equity of 248.14%. The business’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $7.07 EPS. On average, equities research analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is currently 10.21%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Morgan Stanley reissued an “overweight” rating and issued a $966.00 target price on shares of McKesson in a report on Thursday. TD Cowen reissued a “buy” rating on shares of McKesson in a research note on Monday, December 22nd. UBS Group lifted their target price on shares of McKesson from $920.00 to $980.00 and gave the company a “buy” rating in a research note on Thursday, November 6th. Wells Fargo & Company upped their target price on shares of McKesson from $816.00 to $914.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Finally, Weiss Ratings reiterated a “buy (a-)” rating on shares of McKesson in a research note on Monday, December 29th. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, McKesson has a consensus rating of “Moderate Buy” and an average target price of $899.36.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.